CI
Conning Inc Portfolio holdings
AUM
$2.91B
This Quarter Return
+2.33%
1 Year Return
+12.27%
3 Year Return
+38.61%
5 Year Return
+77.33%
10 Year Return
+147.58%
AUM
$2.99B
AUM Growth
+$2.99B
(-0.05%)
Cap. Flow
-$59.8M
Cap. Flow
% of AUM
-2%
Top 10 Holdings %
Top 10 Hldgs %
15.22%
Holding
376
New
5
Increased
52
Reduced
221
Closed
27
Top Buys
| 1 |
Coterra Energy
CTRA
|
$32.1M |
| 2 |
Vanguard Long-Term Bond ETF
BLV
|
$10.5M |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
$7.57M |
| 4 |
PNC Financial Services
PNC
|
$7.19M |
| 5 |
Target
TGT
|
$6.37M |
Top Sells
| 1 |
Tyson Foods
TSN
|
$35.2M |
| 2 |
Amgen
AMGN
|
$32.3M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$15.3M |
| 4 |
Broadcom
AVGO
|
$14.5M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
$6.17M |
Sector Composition
| 1 | Financials | 13.37% |
| 2 | Technology | 12.94% |
| 3 | Industrials | 10.46% |
| 4 | Consumer Staples | 9.83% |
| 5 | Healthcare | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bank of America
BAC
$371B
| $36.3M | 1.21% |
1,265,966
+176,006
| +16% | +$5.04M |
|
27
Johnson & Johnson
JNJ
$429B
| $36.3M | 1.21% |
219,443
-11,819
| -5% | -$1.95M |
|
28
Best Buy
BBY
$15.8B
| $36.2M | 1.21% |
442,373
+36,778
| +9% | +$3.01M |
|
29
iShares Core S&P Small-Cap ETF
IJR
$84.4B
| $36.2M | 1.21% |
362,851
-25,015
| -6% | -$2.49M |
|
30
iShares MBS ETF
MBB
$40.9B
| $36.2M | 1.21% |
387,672
| – | – |
|
31
ConocoPhillips
COP
$118B
| $36M | 1.2% |
347,814
-3,025
| -0.9% | -$313K |
|
32
Blackrock
BLK
$170B
| $36M | 1.2% |
52,137
-826
| -2% | -$570K |
|
33
Pfizer
PFE
$141B
| $35.9M | 1.2% |
981,377
+22,357
| +2% | +$819K |
|
|
34
PNC Financial Services
PNC
$80.7B
| $35.9M | 1.2% |
285,304
+57,235
| +25% | +$7.19M |
|
35
Coca-Cola
KO
$297B
| $35.7M | 1.19% |
594,198
-31,224
| -5% | -$1.88M |
|
36
Mondelez International
MDLZ
$79.3B
| $35.6M | 1.19% |
489,223
-81,197
| -14% | -$5.91M |
|
37
Paychex
PAYX
$48.8B
| $35.6M | 1.19% |
318,720
-5,145
| -2% | -$574K |
|
38
Kimberly-Clark
KMB
$42.5B
| $35.5M | 1.19% |
257,343
-28,726
| -10% | -$3.96M |
|
39
Bristol-Myers Squibb
BMY
$96.7B
| $35.4M | 1.19% |
555,361
+10,929
| +2% | +$698K |
|
40
CME Group
CME
$97.1B
| $35.4M | 1.18% |
191,211
-1,872
| -1% | -$346K |
|
41
Ameriprise Financial
AMP
$47.8B
| $35.3M | 1.18% |
106,586
+7,595
| +8% | +$2.52M |
|
42
Abbott
ABT
$230B
| $35.2M | 1.18% |
323,866
-16,258
| -5% | -$1.77M |
|
43
Gilead Sciences
GILD
$140B
| $35.2M | 1.18% |
457,939
+6,748
| +1% | +$519K |
|
|
44
Target
TGT
$42B
| $35.2M | 1.18% |
267,380
+48,354
| +22% | +$6.37M |
|
45
McDonald's
MCD
$226B
| $35.1M | 1.17% |
117,876
-15,183
| -11% | -$4.52M |
|
46
CVS Health
CVS
$93B
| $34.8M | 1.17% |
504,833
+75,717
| +18% | +$5.22M |
|
47
Travelers Companies
TRV
$62.3B
| $34.8M | 1.16% |
200,815
+6,936
| +4% | +$1.2M |
|
48
Lockheed Martin
LMT
$105B
| $34.4M | 1.15% |
74,969
+363
| +0.5% | +$167K |
|
49
Colgate-Palmolive
CL
$67.7B
| $34.4M | 1.15% |
447,511
-29,076
| -6% | -$2.24M |
|
50
EOG Resources
EOG
$65.8B
| $34.2M | 1.14% |
299,111
-875
| -0.3% | -$99.9K |
|